Wolters Kluwer appoints Greg Samios as President & CEO of Clinical Effectiveness, Dr. Peter Bonis as Chief Medical Officer for the Health division
11 November 2021 - 2:50PM
Wolters Kluwer appoints Greg Samios as President & CEO of
Clinical Effectiveness, Dr. Peter Bonis as Chief Medical Officer
for the Health division
Wolters Kluwer
appoints Greg Samios as
President & CEO
of Clinical
Effectiveness, Dr. Peter Bonis as
Chief Medical Officer for
the Health division
November 11, 2021 –
Wolters Kluwer Health
announces the appointments of Gregory
Samios as President &
CEO of Clinical
Effectiveness and Dr. Peter Bonis as Chief Medical
Officer (CMO) of the
division, effective December 1,
2021. The appointments
reflect Wolters Kluwer’s continued
focus on
advancing healthcare
technology and growing expert
solutions across the continuum of
healthcare.
As President and CEO for Clinical Effectiveness, the largest
business within Wolters Kluwer’s Clinical Solutions group, Samios
succeeds Dr. Denise Basow, who is leaving Wolters Kluwer after 25
years of service. Samios brings decades of experience as a
customer-focused executive in the healthcare and legal information
sectors. Most recently, he served as President and CEO of Health
Learning, Research & Practice (HLRP). Throughout his career,
Samios has been passionate about working together with customers to
understand their unique challenges and deliver deep impact where it
matters most. He employs lean principles to all aspects of business
transformation to stimulate innovation and cultivate industry
partnerships as vital to building value creation. Samios joined
Wolters Kluwer in 2014, serving as President and CEO of the Wolters
Kluwer Legal & Regulatory U.S. business before moving to the
Health Division to lead HLRP in 2019. Previously, he held executive
leadership roles at Kaplan Test Prep and Admissions, Reed Elsevier,
Excerpta Medica, and Elsevier Health Sciences. Samios earned an MBA
at Duke University and graduated from the University of Rochester
with a B.S. and M.S. in Engineering.
Dr. Bonis, who has served as Chief Medical Officer of Clinical
Effectiveness since 2015, will now expand his scope to oversee
division-wide industry partnerships, research and development
initiatives, and deep collaborations with customers and partners.
He joined Wolters Kluwer in 2008 as part of the acquisition of
UpToDate where he has served since 1998. He was instrumental to the
development of UpToDate into the leading clinical decision support
tool used by doctors globally and in bringing our drug information
and patient engagement products together with UpToDate under
Clinical Effectiveness. Dr. Bonis is a graduate of Harvard
University and New York University School of Medicine. He was an
assistant professor at Yale University School of Medicine and is
currently an adjunct professor of medicine at Tufts University
School of Medicine.
“Healthcare technology is rapidly changing the ways patients
receive care, how clinicians make better decisions, and even how
students learn to practice. I am excited to work with Greg and
Peter in their new expanded roles to accelerate the innovation and
customer success we deliver across our solutions at such an
important time in the industry and global healthcare markets,” said
Stacey Caywood, Chief Executive Officer, Wolters Kluwer Health.
The Clinical Effectiveness business, which is part of Clinical
Solutions, includes our UpToDate clinical decision support
solutions, Lexicomp® and Medi-Span® clinical drug information, and
the Emmi® patient engagement solutions.
###
About Wolters KluwerWolters Kluwer (WKL) is a
global leader in professional information, software solutions, and
services for the clinicians, nurses, accountants, lawyers, and tax,
finance, audit, risk, compliance, and regulatory sectors. We help
our customers make critical decisions every day by providing expert
solutions that combine deep domain knowledge with advanced
technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion.
The group serves customers in over 180 countries, maintains
operations in over 40 countries, and employs approximately 19,200
people worldwide. The company is headquartered in Alphen aan den
Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and
evidence-based solutions that engage clinicians, patients,
researchers and students in effective decision-making and outcomes
across healthcare. We support clinical effectiveness, learning and
research, clinical surveillance and compliance, as well as data
solutions. For more information about our solutions, visit
https://www.wolterskluwer.com/en/health and follow us on LinkedIn
and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on
Twitter, Facebook, LinkedIn, and YouTube.
Media André RebeloSr. Global Public Relations
ManagerWolters Kluwer Health+1 (781)
392-2411andre.rebelo@wolterskluwer.com
- 2021.11.11 Wolters Kluwer appoints Greg Samios as President CEO
of Clinical Effectiveness Dr. Peter Bonis as Chief Medical Officer
for the Health div
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Wolters Kluwers NV (EU:WKL)
Historical Stock Chart
Von Apr 2023 bis Apr 2024